Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.7%

2 terminated out of 23 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (3)
P 2 (4)
P 3 (1)
P 4 (1)

Trial Status

Completed12
Unknown3
Recruiting2
Not Yet Recruiting2
Terminated2
Withdrawn1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT06765681Active Not Recruiting

An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related

NCT04580563Not ApplicableCompleted

Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study

NCT06373159Completed

An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan

NCT07234630Not Yet Recruiting

Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy

NCT04356950Completed

Analysis of the Coagulopathy Developed by COVID-19 Infected Patients

NCT06363149Recruiting

Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients

NCT04107402Not ApplicableCompleted

PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock

NCT00506519Phase 2TerminatedPrimary

Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis

NCT06727669Recruiting

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

NCT06626880Not Yet RecruitingPrimary

Predictive Value of Scoring System in Neonates with Disseminated Intravascular Coagulation

NCT04547153Phase 2Completed

Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC

NCT02654561Phase 3Unknown

Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation

NCT05995093UnknownPrimary

The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation

NCT03714048Completed

Blood Management During ECMO for Cardiac Support

NCT04873349Not ApplicableCompleted

Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients

NCT04460664Completed

Coagulation Changes Associated With COVID-19 Infection

NCT04363840Phase 2Withdrawn

The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations

NCT04356144CompletedPrimary

Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections

NCT03716310Completed

Platelet Reactivity in Septic Shock

NCT03577015UnknownPrimary

International Prospective Registry of Disseminated Intravascular Coagulation

Scroll to load more

Research Network

Activity Timeline